Search and Track the Federal Register
Department or Agency:
Show:
Regulations Filed: All Dates
Between and
Full Text (optional):


Food and Drug Administration – Federal Register Recent Federal Regulation Documents

Results 1 - 50 of over 3,100
Document Doc Number PDF Type Agency
November 6, 2009
Agency Information Collection Activities; Proposals, Submissions, and Approvals 57491–57493 [E9–26760] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0507] Agency Information Collection Activities: Proposed Collection; Comment Request; Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 57495–57496 [E9–26850] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0506] Agency Information Collection Activities; Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act... [read document]
 
Guidance for Industry and Food and Drug Administration Staff: In Vitro Diagnostic 2009 H1N1 Tests for Use in 2009 H1N1 Emergency; Availability 57503–57504 [E9–26737] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0319] Guidance for Industry and Food and Drug Administration Staff; In Vitro Diagnostic 2009 H1N1 Tests for Use in the 2009 H1N1 Emergency; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled ``In Vitro Diagnostic 2009 H1N1 Tests for Use in the 2009 H1N1 Emergency.'' FDA is issuing... [read document]
 
November 5, 2009
Listing of Color Additives Exempt From Certification: Astaxanthin Dimethyldisuccinate 57248–57251 [E9–26524] PDF Rule Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 73 [Docket No. FDA-2007-C-0044] (formerly Docket No. 2007C-0474) Listing of Color Additives Exempt From Certification; Astaxanthin Dimethyldisuccinate AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the color additive regulations to provide for the safe use of astaxanthin dimethyldisuccinate as a color additive in the feed of salmonid fish... [read document]
 
Amendment to Memorandum of Understanding: Food and Drug Administration and WebMD, LLC 57316–57318 [E9–26674] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0667] [FDA-2008-N-0043] Amendment to Memorandum of Understanding Between the Food and Drug Administration and WebMD, LLC AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is providing notice of an amendment to a memorandum of understanding (MOU) between FDA's Office of External Relations and WebMD, LLC. DATES: The amendment became effective October... [read document]
 
Food and Drug Administration's Safe Use Initiative; Availability of Information 57319–57320 [E9–26530] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0526] Food and Drug Administration's Safe Use Initiative; Availability of Information AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the launch of its Safe Use Initiative with the release of a report titled ``FDA's Safe Use Initiative--Collaborating to Reduce Preventable Harm from Medicines.'' FDA is opening a docket to enable the... [read document]
 
Amendment to Memorandum of Understanding: Dosage Delivery Devices for Over-The-Counter Liquid Drug Products; Availability 57319 [E9–26531] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0322] Draft Guidance for Industry on Dosage Delivery Devices for Over- The-Counter Liquid Drug Products; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry titled ``Dosage Delivery Devices for OTC Liquid Drug Products.'' FDA is issuing this guidance because of ongoing... [read document]
 
November 4, 2009
Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Tomatoes; Extension of Comment Period 57179–57180 [E9–26636] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0346] Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Tomatoes; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. SUMMARY: The Food and Drug Administration (FDA) is extending to January 4, 2010, the comment period for the draft guidance entitled ``Guidance for Industry: Guide to Minimize Microbial Food... [read document]
 
Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Melons; Extension of Comment Period 57179 [E9–26638] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0347] Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Melons; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. SUMMARY: The Food and Drug Administration (FDA) is extending to January 4, 2010, the comment period for the draft guidance entitled ``Guidance for Industry: Guide to Minimize Microbial Food Safety... [read document]
 
Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Leafy Greens; Extension of Comment Period 57180 [E9–26637] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0348] Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Leafy Greens; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. SUMMARY: The Food and Drug Administration (FDA) is extending to January 4, 2010, the comment period for the draft guidance entitled ``Guidance for Industry: Guide to Minimize Microbial Food... [read document]
 
November 3, 2009
Draft Guidance for Industry on Listing of Ingredients in Tobacco Products; Availability 56842–56843 [E9–26466] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0524] Draft Guidance for Industry on Listing of Ingredients in Tobacco Products; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Listing of Ingredients in Tobacco Products.'' The draft guidance document is intended to assist persons making tobacco product... [read document]
 
Meetings: Product Tracing Systems for Food 56843–56855 [E9–26479] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0523] Product Tracing Systems for Food; Public Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice; request for comment. SUMMARY: The Food and Drug Administration (FDA), in collaboration with the United States Department of Agriculture, Food Safety and Inspection Service (FSIS), is announcing a public meeting regarding product tracing systems for food intended for humans and animals. The... [read document]
 
Meetings: International Conference on Harmonisation S2 Genetic Toxicology Issues; Request for Comments 56856–56857 [E9–26397] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0519] Public Workshop: International Conference on Harmonisation S2 Genetic Toxicology Issues; Request for Comments AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public workshop; request for comments. SUMMARY: The Food and Drug Administration (FDA) is announcing a public workshop entitled ``ICH S2 Genetic Toxicology Issues.'' The 1-day public workshop is intended to seek constructive input... [read document]
 
November 2, 2009
Agency Information Collection Activities; Proposals, Submissions, and Approvals 56642–56643 [E9–26307] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0360] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration Public Health Notification Readership Survey (Formerly Known as ``Safety Alert/Public Health Advisory Readership Survey'') AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 56643–56644 [E9–26290] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0497] Agency Information Collection Activities; Proposed Collection; Comment Request; Abbreviated New Animal Drug Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal... [read document]
 
Authorization of Emergency Use of the Antiviral Product Peramivir Accompanied by Emergency Use Information 56644–56649 [E9–26291] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0521] Authorization of Emergency Use of the Antiviral Product Peramivir Accompanied by Emergency Use Information; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) for peramivir 200 milligrams (mg)/20 milliliter (mL) (10 mg/mL) single use vial... [read document]
 
Meetings: Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee 56650–56651 [E9–26259] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Gastroenterology and Urology Devices Panel of the Medical... [read document]
 
Meetings: Ear, Nose, and Throat Devices Panel of the Medical Devices Advisory Committee 56651–56652 [E9–26260] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Ear, Nose, and Throat Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Ear, Nose, and Throat Devices Panel of the Medical Devices Advisory... [read document]
 
Meetings: Pediatric Advisory Committee; Amendment 56652 [E9–26262] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2009-N-0664] Pediatric Advisory Committee; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pediatric Advisory Committee. This meeting was announced in the Federal Register of October 6, 2009 (74 FR 51289). The amendment is being made to reflect a change in the Agenda portion of the... [read document]
 
Meetings: Neurological Devices Panel of the Medical Devices Advisory Committee; Postponement 56655 [E9–26261] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Postponement of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is postponing the meeting of the Neurological Devices Panel of the Medical Devices Advisory Committee scheduled for November 20, 2009. This meeting was announced in the Federal Register of... [read document]
 
October 29, 2009
Investigational New Drug Applications; Technical Amendment 55770–55771 [E9–26095] PDF Rule Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 312 [Docket No. FDA-2009-N-0464] Investigational New Drug Applications; Technical Amendment AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; technical amendment. SUMMARY: The Food and Drug Administration (FDA) is amending its investigational new drug application (IND) regulations to add an address for applicants to submit INDs for in vivo bioavailability and bioequivalence studies in humans. INDs for... [read document]
 
October 28, 2009
Agency Information Collection Activities; Proposals, Submissions, and Approvals 55556–55557 [E9–25915] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0511] Agency Information Collection Activities; Proposed Collection; Comment Request; Medicated Feed Mill License Application AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 55557–55558 [E9–25927] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0215] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Recordkeeping Requirements for Microbiological Testing and Corrective Measures for Bottled Water AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the... [read document]
 
Draft Guidance for Industry and Reviewers: Structured Product Labeling Standard for Content of Labeling Technical Questions and Answers, Revision 55562–55564 [E9–25940] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0355] Draft Guidance for Industry and Reviewers on Structured Product Labeling Standard for Content of Labeling Technical Questions and Answers, Revision; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a draft revised guidance for industry and reviewers entitled ``SPL Standard for Content of... [read document]
 
Draft Guidance for Industry and Reviewers: Science Advisory Board to the National Center for Toxicological Research 55564–55565 [E9–25941] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Science Advisory Board to the National Center for Toxicological Research Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public. Name of Committee: Science Advisory Board (SAB) to the National... [read document]
 
October 27, 2009
Meetings: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee 55243 [E9–25806] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory... [read document]
 
Meetings: Endocrinologic and Metabolic Drugs Advisory Committee 55243–55244 [E9–25805] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Endocrinologic and Metabolic Drugs Advisory Committee. General Function of the Committee: To... [read document]
 
Public Workshop: Emerging Arboviruses; Risk Assessment for Blood, Cell, Tissue, and Organ Safety 55244–55245 [E9–25802] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Emerging Arboviruses: Risk Assessment for Blood, Cell, Tissue, and Organ Safety; Public Workshop AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public workshop. The Food and Drug Administration (FDA) is announcing a public workshop entitled ``Emerging Arboviruses: Risk Assessment for Blood, Cell, Tissue and Organ Safety.'' The purpose of the public workshop is to assess the risk and... [read document]
 
Prescription Drug User Fee Rates for Fiscal Year 2010; Correction 55244 [E9–25804] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0339] Prescription Drug User Fee Rates for Fiscal Year 2010; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration is correcting a notice that appeared in the Federal Register of August 3, 2009 (74 FR 38451). The document announced the fiscal year 2010 fee rates for the Prescription Drug User Fee Act. The document was published with... [read document]
 
Public Workshop: Request for Safety and Effectiveness Data; Withdrawal 55245–55246 [E9–25803] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2004-N-0063] (formerly Docket No. 2004N-0346) Saccharomyces boulardii Eligibility for Consideration To Be Added to the Over-the-Counter Drug Monograph for Antidiarrheal Drug Products; Request for Safety and Effectiveness Data; Withdrawal AGENCY: Food and Drug Administration, HHS. ACTION: Withdrawal of notice of eligibility and request for data and information. SUMMARY: We (Food and Drug Administration (FDA))... [read document]
 
October 26, 2009
Agency Information Collection Activities; Proposals, Submissions, and Approvals 55046–55048 [E9–25671] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0512] Agency Information Collection Activities; Proposed Collection; Comment Request; Antimicrobial Animal Drug Distribution Reports Under Section 105 of the Animal Drug User Fee Amendments of 2008 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 55050–55051 [E9–25604] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0496] Agency Information Collection Activities; Proposed Collection; Comment Request; Tobacco Product Standard for Flavored Cigarettes AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA),... [read document]
 
Guidance for Industry on Investigator Responsibilities: Protecting the Rights, Safety, and Welfare of Study Subjects; Availability 55052–55053 [E9–25629] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2007-D-0307 (formerly Docket No. 2007-D-0173)] Guidance for Industry on Investigator Responsibilities-- Protecting the Rights, Safety, and Welfare of Study Subjects; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled ``Investigator Responsibilities--Protecting the Rights,... [read document]
 
Guidance for Industry on Investigator Responsibilities: Anti-Infective Drugs Advisory Committee 55056–55057 [E9–25627] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Anti-Infective Drugs Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Anti-Infective Drugs Advisory Committee. General Function of the Committee: To provide advice and... [read document]
 
Guidance for Industry on Investigator Responsibilities: 55057 [E9–25628] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Anti-Infective Drugs Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Anti-Infective Drugs Advisory Committee. General Function of the Committee: To provide advice and... [read document]
 
October 23, 2009
New Animal Drug Applications 54749–54751 [E9–25517] PDF Rule Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 514 [Docket No. FDA-2009-N-0436] New Animal Drug Applications AGENCY: Food and Drug Administration, HHS. ACTION: Direct final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the regulations regarding new animal drug applications (NADAs). Specifically, this direct final rule is being issued to provide that NADAs shall be submitted in the described form, as appropriate for the particular submission.... [read document]
 
New Animal Drug Applications 54771–54773 [E9–25518] PDF Proposed Rule Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 514 [Docket No. FDA-2009-N-0436] New Animal Drug Applications AGENCY: Food and Drug Administration, HHS. ACTION: Proposed rule. SUMMARY: The Food and Drug Administration (FDA) is proposing to amend the regulations regarding new animal drug applications (NADAs). Specifically, this proposed rule is being issued to provide that NADAs shall be submitted in the form and containing the information described, as... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 54824–54826 [E9–25539] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0480] Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational Device Exemptions Reports and Records AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 54826–54827 [E9–25538] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0486] Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry, FDA, and Foreign Governments: Fiscal Year 2010 Medical Device User Fee Small Business Qualification and Certification AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 54827–54829 [E9–25537] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0505] Agency Information Collection Activities; Proposed Collection; Comment Request; Recordkeeping and Reporting Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing, Material From Cattle AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed... [read document]
 
October 22, 2009
Agency Information Collection Activities; Proposals, Submissions, and Approvals 54570–54571 [E9–25395] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0474] Agency Information Collection Activities; Proposed Collection; Comment Request; Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of 2002 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the... [read document]
 
Meetings: Radiological Devices Panel of the Medical Devices Advisory Committee 54583 [E9–25406] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Radiological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Radiological Devices Panel of the Medical Devices Advisory Committee. General... [read document]
 
Meetings: Nonvoting Industry Representatives on Public Advisory Committees, et al. 54589–54590 [E9–25407] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0664] Request for Notification From Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives on Public Advisory Committees and Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committees AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting that any... [read document]
 
October 20, 2009
Agency Information Collection Activities; Proposals, Submissions, and Approvals 53743–53746 [E9–25102] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0296] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food Labeling Regulations AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 53746–53749 [E9–25100] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0501] Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 53749–53750 [E9–25178] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0487] Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance on Informed Consent For In Vitro Diagnostic Device Studies Using Leftover Human Specimens That Are Not Individually Identifiable AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection... [read document]
 
Agency Information Collection Activities; Proposals, Submissions, and Approvals 53750–53751 [E9–25177] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-N-0489] Agency Information Collection Activities; Proposed Collection; Comment Request; Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the... [read document]
 
Draft Guidance for Industry and Food and Drug Administration Staff: Investigational New Drug Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood, etc. 53751–53752 [E9–25136] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2009-D-0490] Draft Guidance for Industry and Food and Drug Administration Staff: Investigational New Drug Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the... [read document]
 
Draft Guidance for Industry and Food and Drug Administration Staff: Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications 53753–53754 [E9–25135] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2006-D-0157] (Formerly Docket No. 2006D-0514) Guidance for Industry: Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled ``Guidance for... [read document]
 
Web Location of 2010 Proposed Guidance Development 53754–53755 [E9–25179] PDF Notice Food and Drug Administration
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2007-N-0270] Medical Device User Fee and Modernization Act; Notice to Public of Web Location of 2010 Proposed Guidance Development AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the Web location where it will post a list of guidance documents the Center for Devices and Radiological Health (CDRH) is considering for development. In... [read document]
 
        Next >
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck